rs539338883
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_014846.4(WASHC5):c.*125A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000372 in 752,434 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000053 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000033 ( 0 hom. )
Consequence
WASHC5
NM_014846.4 3_prime_UTR
NM_014846.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0300
Publications
0 publications found
Genes affected
WASHC5 (HGNC:28984): (WASH complex subunit 5) This gene encodes a 134 kDa protein named strumpellin that is predicted to have multiple transmembrane domains and a spectrin-repeat-containing domain. This ubiquitously expressed gene has its highest expression in skeletal muscle. The protein is named for Strumpell disease; a form of hereditary spastic paraplegia (HSP). Spastic paraplegias are a diverse group of disorders in which the autosomal dominant forms are characterized by progressive, lower extremity spasticity caused by axonal degeneration in the terminal portions of the longest descending and ascending corticospinal tracts. More than 30 loci (SPG1-33) have been implicated in hereditary spastic paraplegia diseases. [provided by RefSeq, Aug 2009]
WASHC5 Gene-Disease associations (from GenCC):
- Ritscher-Schinzel syndrome 1Inheritance: AR Classification: STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
- hereditary spastic paraplegia 8Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Ritscher-Schinzel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WASHC5 | NM_014846.4 | c.*125A>G | 3_prime_UTR_variant | Exon 29 of 29 | ENST00000318410.12 | NP_055661.3 | ||
WASHC5 | NM_001330609.2 | c.*125A>G | 3_prime_UTR_variant | Exon 28 of 28 | NP_001317538.1 | |||
WASHC5 | XM_047422502.1 | c.*125A>G | 3_prime_UTR_variant | Exon 30 of 30 | XP_047278458.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WASHC5 | ENST00000318410.12 | c.*125A>G | 3_prime_UTR_variant | Exon 29 of 29 | 1 | NM_014846.4 | ENSP00000318016.7 | |||
WASHC5 | ENST00000519042.2 | n.744A>G | non_coding_transcript_exon_variant | Exon 3 of 3 | 2 | |||||
WASHC5 | ENST00000517845.5 | c.*125A>G | 3_prime_UTR_variant | Exon 27 of 27 | 2 | ENSP00000429676.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152190Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
8
AN:
152190
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000333 AC: 20AN: 600244Hom.: 0 Cov.: 7 AF XY: 0.0000247 AC XY: 8AN XY: 324300 show subpopulations
GnomAD4 exome
AF:
AC:
20
AN:
600244
Hom.:
Cov.:
7
AF XY:
AC XY:
8
AN XY:
324300
show subpopulations
African (AFR)
AF:
AC:
0
AN:
16766
American (AMR)
AF:
AC:
0
AN:
36590
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
20094
East Asian (EAS)
AF:
AC:
0
AN:
34350
South Asian (SAS)
AF:
AC:
0
AN:
64668
European-Finnish (FIN)
AF:
AC:
0
AN:
50264
Middle Eastern (MID)
AF:
AC:
1
AN:
3686
European-Non Finnish (NFE)
AF:
AC:
19
AN:
342154
Other (OTH)
AF:
AC:
0
AN:
31672
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74352 show subpopulations
GnomAD4 genome
AF:
AC:
8
AN:
152190
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74352
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41448
American (AMR)
AF:
AC:
0
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5190
South Asian (SAS)
AF:
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
8
AN:
68038
Other (OTH)
AF:
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Hereditary spastic paraplegia Uncertain:1
Dec 20, 2016
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.